Ponicidin suppresses HT29 cell growth via the induction of G1 cell cycle arrest and apoptosis

Du,Jie; Chen,Chunyou; Sun,Yiqun; Zheng,Lin; Wang,Wanchen

doi:10.3892/mmr.2015.4150

Ponicidin suppresses HT29 cell growth via the induction of G1 cell cycle arrest and apoptosis

Authors:
- Jie Du
- Chunyou Chen
- Yiqun Sun
- Lin Zheng
- Wanchen Wang
View Affiliations

Affiliations: Department of General Surgery, Port Hospital of Tianjin, Tianjin 300456, P.R. China
Published online on: July 29, 2015 https://doi.org/10.3892/mmr.2015.4150
Pages: 5816-5820
Copyright: © Du et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ponicidin is a diterpenoid extracted from the Chinese herb Isodon adenolomus, which has been reported as a therapeutic cytotoxic drug that may be used to treat various types of human cancer. The present study aimed to determine the antitumor effects of ponicidin, and to investigate its underlying mechanisms in colorectal cancer. The HT29 colorectal cancer cell line was used to detect the cytotoxicity of various doses of ponicidin. Cell proliferation was measured using a Cell Counting kit‑8 assay. Cell cycle and apoptosis analyses were performed using flow cytometry and fluorescent microscopy. Western blot analysis was used to measure the expression levels of apoptosis‑associated proteins following treatment with ponicidin. Treatment with ponicidin significantly suppressed HT29 cell growth by inducing G1 cell cycle arrest and apoptosis. The AKT and MEK signaling pathways were also suppressed by ponicidin; however, the p38 signaling pathway was significantly activated. The expression levels of caspase 3 and Bax protein were markedly upregulated following treatment with ponicidin. These results suggest that ponicidin exerts significant antitumor effects via the induction of cell cycle arrest and apoptosis in colorectal cells. In conclusion, ponicidin acted as an inducer of apoptosis, and may be used as a therapeutic cytotoxic drug to treat human cancer, including colorectal cancer.

View Figures

View References

1	Zhang JX, Han QB, Zhao AH and Sun HD: Diterpenoids from Isodon japonica. Fitoterapia. 74:435–438. 2003. View Article : Google Scholar : PubMed/NCBI
2	Zhao W, Pu JX, Du X, Su J, Li XN, Yang JH, Xue YB, Li Y, Xiao WL and Sun HD: Structure and cytotoxicity of diterpenoids from Isodon adenolomus. J Nat Prod. 74:1213–1220. 2011. View Article : Google Scholar : PubMed/NCBI
3	Osawa K, Yasuda H, Maruyama T, Morita H, Takeya K and Itokawa H: Antibacterial trichorabdal diterpenes from Rabdosia trichocarpa. Phytochemistry. 36:1287–1291. 1994. View Article : Google Scholar : PubMed/NCBI
4	Zhang JF, Liu PQ, Chen GH, Lu MQ, Cai CJ, Yang Y and Li H: Ponicidin inhibits cell growth on hepatocellular carcinoma cells by induction of apoptosis. Dig Liver Dis. 39:160–166. 2007. View Article : Google Scholar
5	Liu JJ, Huang RW, Lin DJ, Peng J, Zhang M, Pan X, Hou M, Wu XY, Lin Q and Chen F: Ponicidin, an ent-kaurane diterpenoid derived from a constituent of the herbal supplement PC-SPES, Rabdosia rubescens, induces apoptosis by activation of caspase-3 and mitochondrial events in lung cancer cells in vitro. Cancer Invest. 24:136–148. 2006. View Article : Google Scholar : PubMed/NCBI
6	Bai N, He K, Zhou Z, Tsai ML, Zhang L, Quan Z, Shao X, Pan MH and Ho CT: Ent-kaurane diterpenoids from Rabdosia rubescens and their cytotoxic effects on human cancer cell lines. Planta Med. 76:140–145. 2010. View Article : Google Scholar
7	Liu JJ, Zhang Y, Guang WB, Yang HZ, Lin DJ and Xiao RZ: Ponicidin inhibits monocytic leukemia cell growth by induction of apoptosis. Int J Mol Sci. 9:2265–2277. 2008. View Article : Google Scholar
8	Zhou Y, Wan G, Spizzo R, Ivan C, Mathur R, Hu X, Ye X, Lu J, Fan F, Xia L, et al: miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Mol Oncol. 8:83–92. 2014. View Article : Google Scholar :
9	de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 18:2938–2947. 2000.PubMed/NCBI
10	Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, van Buren G II, Samuel S, Kim MP, Lim SJ and Ellis LM: Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res. 69:1951–1957. 2009. View Article : Google Scholar : PubMed/NCBI
11	Ergil KV, Kramer EJ and Ng AT: Chinese herbal medicines. West J Med. 176:275–279. 2002.PubMed/NCBI
12	Au AM, Ko R, Boo FO, Hsu R, Perez G and Yang Z: Screening methods for drugs and heavy metals in Chinese patent medicines. Bull Environ Contam Toxicol. 65:112–119. 2000. View Article : Google Scholar : PubMed/NCBI
13	Mujumdar N, Banerjee S, Chen Z, Sangwan V, Chugh R, Dudeja V, Yamamoto M, Vickers SM and Saluja AK: Triptolide activates unfolded protein response leading to chronic ER stress in pancreatic cancer cells. Am J Physiol Gastrointest Liver Physiol. 306:G1011–G1020. 2014. View Article : Google Scholar : PubMed/NCBI
14	Kostenko S, Dumitriu G, Lægreid KJ and Moens U: Physiological roles of mitogen-activated-protein-kinase-activated p38-regulated/activated protein kinase. World J Biol Chem. 2:73–89. 2011. View Article : Google Scholar : PubMed/NCBI
15	Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H and Haga N: Molecular targeting therapy of cancer: Drug resistance, apoptosis and survival signal. Cancer Sci. 94:15–21. 2003. View Article : Google Scholar : PubMed/NCBI
16	Li X, Chu Y, Du B, Wang L and Yu T: LC-MS-MS for the determination of ponicidin in dog plasma. J Chromatogr Sci. 52:211–217. 2014. View Article : Google Scholar
17	Ma B, Wang Y, Zhang Q, Liu Y, Li J, Xu Q and Ying H: Simultaneous determination of oridonin, ponicidin and rosmarinic acid from Herba Isodi Rubescentis extract by LC-MS-MS in rat plasma. J Chromatogr Sci. 51:910–918. 2013. View Article : Google Scholar : PubMed/NCBI
18	Li X, Hou W, Song J, Liu H, Song S, Zhang L and Shi Y: A simple and sensitive HPLC-UV method for the determination of ponicidin in rat plasma and its application in a pharmacokinetic study. Biomed Chromatogr. 25:362–366. 2011. View Article : Google Scholar
19	Du Y, Liu P, Shi X, Jin Y, Wang Q, Zhang X, Sheng X and Zhang L: A novel analysis method for diterpenoids in rat plasma by liquid chromatography-electrospray ionization mass spectrometry. Anal Biochem. 407:111–119. 2010. View Article : Google Scholar : PubMed/NCBI
20	Xu X, Ke Y, Zhang Q, Qi X and Liu H: DNA binding and cleavage properties of ponicidin. Tumori. 95:348–351. 2009.PubMed/NCBI
21	Cuadrado A and Nebreda AR: Mechanisms and functions of p38 MAPK signalling. Biochem J. 429:403–417. 2010. View Article : Google Scholar : PubMed/NCBI
22	Perego P, Cossa G, Zuco V and Zunino F: Modulation of cell sensitivity to antitumor agents by targeting survival pathways. Biochem Pharmacol. 80:1459–1465. 2010. View Article : Google Scholar : PubMed/NCBI